Transcriptome and DNA Methylation Profiles of Mouse Fetus and Placenta Generated by Round Spermatid Injection

Haibo Zhu, Hao Sun, Dawei Yu, Tianda Li, Tang Hai, Chao Liu, Ying Zhang, Yurong Chen, Xiangpeng Dai, Ziyi Li, Wei Li, Ruizhi Liu, Guihai Feng, Qi ZhouFrontiers in Cell and Developmental Biology 2021 · DOI

Abstract

Low birth efficiency and developmental abnormalities in embryos derived using round spermatid injection (ROSI) limit the clinical application of this method. In this study, embryonic day (E) 11.5 mouse fetuses and corresponding placentas derived from ROSI, intracytoplasmic sperm injection (ICSI), and natural in vivo fertilization (control) were analyzed. Transcriptome and DNA methylation profiles were compared using RNA-sequencing (RNA-seq) and whole-genome bisulfite sequencing (WGBS). Results revealed similar gene expression profiles across all groups, though specific differentially expressed genes (DEGs) were identified: seven in ROSI fetuses and ten in ROSI placentas. No significant differences in CpG methylation or imprinting control region methylation were observed. While 49 repetitive DNA sequences (RS) were abnormally activated in ROSI fetuses, their DNA methylation remained normal. These findings suggest that while ROSI-derived embryos are largely comparable to controls at mid-pregnancy, specific gene expression anomalies warrant further investigation.

Introduction

For individuals with non-obstructive azoospermia, Round Spermatid Injection (ROSI) provides a pathway to biological fatherhood by utilizing immature sperm cells. Despite its potential, ROSI is characterized by lower birth efficiency and a higher incidence of developmental abnormalities compared to Intracytoplasmic Sperm Injection (ICSI). The molecular mechanisms driving these discrepancies—whether due to epigenetic reprogramming failures or transcriptomic errors—have remained largely unknown. This study addresses this gap by performing a comprehensive molecular characterization of ROSI-derived mouse offspring at the critical mid-pregnancy stage (E11.5).

Methodology

The researchers compared three experimental groups: ROSI-derived embryos, ICSI-derived embryos (the clinical standard), and naturally fertilized controls. The study utilized RNA-sequencing (RNA-seq) to profile gene expression in both the fetus and placenta, and Whole-Genome Bisulfite Sequencing (WGBS) to map DNA methylation at single-base resolution. Findings were validated using qRT-PCR. The resulting datasets, including transcriptomic profiles of 16 fetuses and 16 placentas, are archived in the Genome Sequence Archive (GSA) under accession CRA003905.

Results

Global Molecular Stability

The primary finding of the study is the remarkable molecular similarity between ROSI-derived fetuses and their naturally conceived counterparts. Hierarchical clustering of transcriptomic data showed that samples clustered primarily by tissue type (fetus vs. placenta) rather than by fertilization method, indicating that the fundamental developmental program remains intact in ROSI embryos.

Identification of Differentially Expressed Genes (DEGs)

Despite global stability, the study identified a small set of genes that were consistently misregulated in the ROSI group. Specifically, 7 DEGs were found in ROSI fetuses and 10 DEGs in ROSI placentas when compared to both ICSI and control groups. Notable placental DEGs included Ctss (Cathepsin S), which plays a role in placental development. Validation by qRT-PCR confirmed the abnormal expression levels of several genes, including Snhg11, Meg3, Ctss, and H2-Eb1.

Transcriptomic analysis and validation of DEGs in ROSI-derived fetuses and placentas. Panel A shows hierarchical clustering; B and C show Venn diagrams of DEGs; D and E show heatmaps; F-I show qRT-PCR validation.

Epigenetic Profiles and Repetitive Sequences

DNA methylation analysis revealed no widespread differences in CpG methylation across the three groups. Methylation at Imprinting Control Regions (ICRs) was also found to be normal. However, the researchers observed the abnormal activation of 49 repetitive DNA sequences (RS) in ROSI fetuses. Interestingly, the methylation levels of these RS regions were unaffected, suggesting that other epigenetic mechanisms, such as histone modifications, may be responsible for the failure to silence these genomic elements.

Discussion and Future Directions

The study provides a reassuring view of the molecular safety of ROSI at mid-pregnancy, but highlights specific vulnerabilities. A "runt" ROSI fetus with significant growth retardation exhibited hypermethylation and low expression of Fggy and Rec8, suggesting these genes could serve as biomarkers for developmental failure.

While the results suggest that ROSI embryos are largely normal by E11.5, the authors note that earlier developmental stages (pre-implantation) should be investigated to determine if more severe abnormalities occur and are subsequently filtered out. Furthermore, future research should explore other epigenetic layers, such as 3D chromatin architecture, to fully understand the impact of using immature sperm in assisted reproduction.

Summary updated

Abstract

Low birth efficiency and developmental abnormalities in embryos derived using round spermatid injection (ROSI) limit the clinical application of this method. Further, the underlying molecular mechanisms remain elusive and warrant further in-depth study. In this study, the embryonic day (E) 11.5 mouse fetuses and corresponding placentas derived upon using ROSI, intracytoplasmic sperm injection (ICSI), and natural <i>in vivo</i> fertilized (control) embryos were collected. Transcriptome and DNA methylation profiles were analyzed and compared using RNA-sequencing (RNA-seq) and whole-genome bisulfite sequencing, respectively. RNA-seq results revealed similar gene expression profiles in the ROSI, ICSI, and control fetuses and placentas. Compared with the other two groups, seven differentially expressed genes (DEGs) were identified in ROSI fetuses, and ten DEGs were identified in the corresponding placentas. However, no differences in CpG methylation were observed in fetuses and placentas from the three groups. Imprinting control region methylation and imprinted gene expression were the same between the three fetus and placenta groups. Although 49 repetitive DNA sequences (RS) were abnormally activated in ROSI fetuses, RS DNA methylation did not differ between the three groups. Interestingly, abnormal hypermethylation in promoter regions and low expression of <i>Fggy</i> and <i>Rec8</i> were correlated with a crown-rump length less than 6 mm in one ROSI fetus. Our study demonstrates that the transcriptome and DNA methylation in ROSI-derived E11.5 mouse fetuses and placentas were comparable with those in the other two groups. However, some abnormally expressed genes in the ROSI fetus and placenta warrant further investigation to elucidate their effect on the development of ROSI-derived embryos.
BibTeX
@inproceedings{zhu2021transcriptome,
  author = {Haibo Zhu and Hao Sun and Dawei Yu and Tianda Li and Tang Hai and Chao Liu and Ying Zhang and Yurong Chen and Xiangpeng Dai and Ziyi Li and Wei Li and Ruizhi Liu and Guihai Feng and Qi Zhou},
  title = {{Transcriptome and DNA Methylation Profiles of Mouse Fetus and Placenta Generated by Round Spermatid Injection}},
  booktitle = {Frontiers in Cell and Developmental Biology},
  year = {2021},
  doi = {10.3389/fcell.2021.632183},
}
Figure